MIRA
INFORM REPORT
|
Report Date : |
10.10.2008 |
IDENTIFICATION
DETAILS
|
Name : |
AMOUN PHARMACEUTICAL CO SAE |
|
|
|
|
Registered Office : |
1677, El Obour, Cairo-Ismalia
Road, Km-76, First Industrial Zone, El Obour City, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
1989 |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Production of Various Chemicals |
RATING &
COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
US$ 2,000,000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
SUMMARY
Company Name : AMOUN PHARMACEUTICAL CO SAE
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 1989
Commercial Registration Number : 1677, El Obour
Issued Capital : £E 200,000,000
Paid up Capital : £E 200,000,000
Total Workforce : 1,770
Activities : Production of various chemicals
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Recommended Credit Limit : US$ 2,000,000
COMPANY NAME
AMOUN
PHARMACEUTICAL CO SAE
ADDRESS
Registered & Physical Address
Street : Cairo-Ismalia Road, Km-76
Area : First Industrial Zone, El Obour
City
Town : Cairo
Country : Egypt
Telephone : (20-2) 46149133
/ 46140100
Facsimile : (20-2) 46140165
Email : hr@amoun.com
Premises
Subject operates
from a large suite of offices and a factory that are owned and located in the
Industrial Area of Cairo.
Branch Office
(s)
Location Description
·
125 El Hegaz
Street Rented
office premises
Cairo
Tel: (20-2) 26244515
Fax: (20-2)
26244520
KEY PRINCIPALS
Name Position
· Shukry Raed Chief
Executive Officer
·
Hanan
Fayek Human
Resources Manager
·
Michael
Gergis Finance
Manager
·
George
Yousef Training
& Development Manager
·
Dr. Gehan Abd
El Massih Tadros Production
Manager
·
Refaat
Rashid Commercial
Manager
· Dr Mamdouh Shafiq Export
Manager
LEGAL FORM & OWNERS
Date of Establishment : 1989
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 1677, El
Obour
Authorised
Capital : £E 500,000,000
Issued Capital : £E 200,000,000
Paid up Capital : £E 200,000,000
Name of Shareholder (s) Percentage
· Citigroup
Venture Capital International 93%
·
Egyptian
businessmen and private investors 7%
OPERATIONS
Activities: Engaged in the production of various
chemicals, including amines, raw materials for pharmaceuticals and
parapharmaceutical preparations, as well as aerosol bottles and containers.
Import
Countries: France, Germany
and Belgium
Export
Countries: The United States
of America, Romania, Russia, Kenya, Ethiopia and 14 Arab States
Subject has a
workforce of approximately 1,770 employees.
FINANCIAL DATA
Companies
registered in Egypt are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
BANKERS
·
Banque du
Caire SAE
22 Adly Street
PO Box : 1495
Cairo
Tel : (20-2) 3904554
Fax : (20-2) 3908992
·
Misr
International Bank (MIBANK)
14, Alfy Street
PO Box : 631
Cairo
Tel : (20-2) 5931002
Fax : (20-2) 5912306
·
National Bank
of Egypt
24, Sherif Street
Cairo
Tel : (20-2) 3924175
Fax : (20-2) 3924143
·
Banque Misr
151 Mohamed Farid Street
Cairo
Tel : (20-2) 3912711 / 3912106
Fax : (20-2) 3919779
PAYMENT HISTORY
No complaints
regarding subject’s payments have been reported.
Date of
transaction January 2000 July 2006
Credit amount 10,000 7,000
Amount overdue 0 0
Payment terms 30
days 180
days
Payment Method Letters
of Credit Letters
of Credit
Paying record No
Complaints No
Complaints
Currency Pounds
Sterling Pounds
Sterling
GENERAL COMMENTS
Amoun
Pharmaceutical Co SAE has operations dating back to 1989 and is engaged in the
production of various chemicals, including amines, raw materials for
pharmaceuticals and parapharmaceutical preparations, as well as aerosol bottles
and containers.
Local sources
report that subject’s operating history is clear with payment obligations met
in a timely manner. As such the company is deemed a sound trade risk and the
above credit figure is within subjects financial means.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.72 |
|
UK Pound |
1 |
Rs.82.17 |
|
Euro |
1 |
Rs.65.90 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)